Target intelligence / Profile preview

Transdermal delivery enhancement

Molecular classification
Other
01

Overview

Transdermal delivery enhancement refers to a diverse category of strategies and agents designed to increase the transport of drugs across the skin. These approaches include the use of chemical permeation enhancers (such as dimethyl sulfoxide/DMSO, or natural terpenes like camphor[3]) that disrupt the lipid or protein structure of the stratum corneum, physical methods (such as microneedles and sonophoresis), and vehicles such as vesicles, liposomes, or nanoparticles. Such enhancers do not constitute a therapeutic target in the conventional molecular sense, but rather are enablers of improved drug administration for drugs unable to efficiently cross the skin barrier[1][2][4]. These methods are crucial for drugs with poor oral bioavailability or those degraded in the GI tract, allowing for improved patient compliance, controlled release, and avoidance of first-pass metabolism. Safety considerations are important, as excessive enhancement can cause skin irritation or loss of barrier integrity[1][4].

Other names
Permeation enhancerPenetration enhancerTransdermal absorption improvementSkin permeation enhancerTranscutaneous delivery enhancementTransdermal enhancers
02

Mechanism of action

Disruption or fluidization of stratum corneum lipids; Alteration of protein conformation in the skin barrier; Hydration or overhydration of the stratum corneum; Physical ablation or bypassing of the stratum corneum (e.g., microneedles, sonophoresis); Establishment of a concentration gradient for transdermal movement

03

Biological functions

Drug delivery facilitationSkin barrier modulation
04

Disease associations

Other
05

Safety considerations

Skin irritationErythemaItchingPotential for allergic reactionsTemporary or permanent disruption of skin barrier functionRisk of infection with physical ablation methods

Beyond the preview

Go deeper on Transdermal delivery enhancement.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transdermal delivery enhancement.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call